Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
- 1 May 1996
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (5) , 793-801
- https://doi.org/10.1016/0959-8049(95)00652-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomasBritish Journal of Cancer, 1994
- Invasion and metastasisCurrent Opinion in Oncology, 1992
- Flow Cytometric DNA Index and S-Phase Fraction in Breast Cancer in Relation to Other Prognostic Variables and to Clinical OutcomeActa Oncologica, 1992
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithmCytometry, 1989
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- Proteolytic Mechanisms Operating at the Surface of Invasive CellsPublished by Springer Nature ,1988
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- Convention on nomenclature for DNA cytometryCytometry, 1984